Autor: admin

What is Gen Z’s industry?getty The youngest members of Gen Z are moving away from traditional technology users in favor of new market segments. With 90 million members, Gen Z is much larger than the generation before it – a key statistic for recruiting in growth-oriented organizations. Why is the youngest generation rethinking the most attractive areas of work, and avoiding technology? And which companies or companies have attracted the most interest of the younger generation in the field of work? Gen Z values ​​and user desires Tech companies are low on Gen Z aspirations, according to a survey of…

Read More

Ozempic has been hailed as a promising anti-diabetic drug, but its potential appears to extend far beyond the treatment of Type 2 diabetes. Canadian endocrinologist Daniel J. Drucker — a diabetes pioneer whose work paved the way for Ozempic — shares what’s next for this class of anti-obesity drugs, which take like the GLP-1 hormone to make people feel full and lose weight. These drugs have shown promise in reducing heart and kidney disease. “The first chapter of the GLP-1 innovation focused on [blood sugar] control, and then, weight loss,” Drucker wrote in the journal Science on Friday. "The next…

Read More

MILWAUKEE (AP) – Four days later attempted murder BEFORE President Donald Trump at a rally in Pennsylvania, the public is still in the dark about the extent of his injuries, the treatment the Republican presidential candidate received at the hospital, and whether there may be any lasting effects. in his health.Trump’s campaign has refused to discuss his condition, release medical reports or records, or make the doctor who treated him available, allowing information to leak from Trump, his friends and his family.The first word on Trump’s condition came about half an hour after the shots rang out and Trump fell…

Read More

In numbers Q2 revenue: $10.38 billion It grew by 4% per year Medical device sales: $4.73 billion It grew by 10.2% annually Revenue: $1.3 billion Decreased by 5.3% year-on-year Abbott raised its sales and revenue forecasts for 2024 on Thursday after a better-than-expected second quarter, boosted by growth in its medical device business. Medical device sales increased 10.2% to $4.73 billion, including Abbott’s electrophysiology, structural heart and diabetes divisions. Abbott reported the results in the second quarter earnings call. Stifel analyst Rick Wise wrote in a research note that the increase in medical devices and feedback on 'good practices' is…

Read More

A brutal bone marrow transplant that can "cure" HIV is also an option for leukemia patients. A 60-year-old German man may be the seventh person to be successfully cured of HIV after a stem cell transplant, doctors said Thursday. The painful and dangerous procedure is for people with HIV and acute leukemia, so it’s not an option for nearly all of the nearly 40 million people living with the deadly virus around the world. . The German man, who wished to remain anonymous, was dubbed "the next Berlin patient". The original Berlin patient, Timothy Ray Brown, was the first person…

Read More

Data on people with diabetes show that compared to drugs like glipizide, drugs like semaglutide have significant advantages. Dr. Dear Roach: I have type 2 diabetes. My BMI is 29. My last A1C was 8.4%. I am currently taking metformin and glipizide. I have asked my doctor about new drugs, like Ozempic and Mounjaro, but he is reluctant to give them. We talked about it twice, and he told me that I have to take it for the rest of my life. He also said that if I stop it, the weight will come back. I’ve been overweight most of…

Read More

14 hours agothe Jen Smith, BBC South West Health CorrespondentBBCDr Jennie Button is a partner at Honiton SurgeryDoctors at a GP surgery in Devon say every day is a "heartbreaking" struggle to meet the "overwhelming" demand for services.A GP at Honiton Surgery said it was "very difficult to be a good doctor" given the current workload.A receptionist at the practice said one of the biggest challenges was "aggressive patients".The Department of Health and Social Care says it is making the system more sustainable by "ensuring we train thousands of GPs".Those who work at Honiton Surgery say they want better funding…

Read More

The pitch is all over social media and is irresistible to many people who want to lose weight: Get a copycat version of an expensive, hard-to-find drug like Ozempic or Mounjaro at a fraction of the price.But the company’s boom in the off-label version of the blockbuster drug, which stimulates the GLP-1 hormone and curbs hunger, has made consumers wonder if it’s worth trying. Here’s what you need to know.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. —What is the difference between branded drugs and cheap imitations sold online?Novo Nordisk, which…

Read More

Queensland children will continue to undergo puberty blocker treatment at the state’s gender health centre, despite the drug being banned overseas over concerns of long-term harm .Health Minister Shannon Fentiman told The Courier-Mail the barriers could be life-changing and life-saving for those with gender dysphoria.The announcement that sex hormone injections will not be stopped comes as the results of an independent investigation into Queensland’s gender and sexuality services are published.There were explosive allegations last year of the newborn department when a psychiatrist said that there were negative effects of sex hormones, and that there were not enough pre-natal tests. to…

Read More

When it comes to GLP-1 weight loss drugs, the biggest winners are the pharmaceutical companies behind them. The Danish company Novo Nordisk makes Ozempic and Wegovy based on semaglutide, and has seen the biggest benefits (so far) as a result. Between 2020 – when Ozempic was still available as a diabetes drug – and 2023, its revenue rose 83%, while its profits doubled. If you were smart or lucky enough to buy shares in Novo Nordisk in 2021, the value of your investment will be 3.5 times today. Another pharma company benefiting from the trend is Eli Lily. Behind Novo…

Read More